![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Publisher's version)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
386kB |
| Item Type: | Letter |
|---|---|
| Title: | Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al |
| Creators: |
Immisch, L.  ORCID: https://orcid.org/0000-0001-5072-8583, Papafotiou, G., Popp, O. ORCID: https://orcid.org/0000-0001-6240-4666, Mertins, P. ORCID: https://orcid.org/0000-0002-2245-528X, Blankenstein, T. ORCID: https://orcid.org/0000-0002-3357-4321 and Willimsky, G. ORCID: https://orcid.org/0000-0002-9693-948X
|
| Keywords: | Glioma, HLA-A2 Antigen, Histones, Immunotherapy, Mutation |
| Source: | Journal for ImmunoTherapy of Cancer |
| ISSN: | 2051-1426 |
| Publisher: | BMJ Publishing Group |
| Volume: | 11 |
| Number: | 3 |
| Page Range: | e006784 |
| Date: | 14 March 2023 |
| Official Publication: | https://doi.org/10.1136/jitc-2023-006784 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
